Quick Answer
Aurinia Pharmaceuticals Inc. reported Stockholders Equity of $581.33 million for fiscal year 2025.
Aurinia Pharmaceuticals Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $581.33M | +54.0% |
| 2024 | $377.48M | -0.1% |
| 2023 | $377.95M | -6.8% |
| 2022 | $405.44M | -15.4% |
| 2021 | $479.09M | +17.5% |
| 2020 | $407.75M | +36.6% |
| 2019 | $298.60M | +120.0% |
| 2018 | $135.72M | -23.7% |
| 2017 | $177.92M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $365.77M | -5.7% | +9.1% |
| June 30, 2025 | $335.30M | -8.0% | -4.3% |
| March 31, 2025 | $350.19M | -2.6% | -7.2% |
| December 31, 2024 | $377.48M | -0.1% | -2.7% |
| September 30, 2024 | $388.00M | -1.0% | +6.4% |
| June 30, 2024 | $364.62M | -7.1% | +1.4% |
| March 31, 2024 | $359.48M | -7.9% | -4.9% |
| December 31, 2023 | $377.95M | -6.8% | -3.6% |
- Aurinia Pharmaceuticals Inc. showed an increase of +54.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, Aurinia Pharmaceuticals Inc.’s stockholders equity has grown by 226.7% (from $177.92 million to $581.33 million).
- The most recent figure is from Aurinia Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: